Skip to search formSkip to main contentSkip to account menu

FK 143

Known as: FK-143, FK143 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in rats.
The incidence of hepatocellular carcinoma (HCC) is more prevalent in males than in females. 5alpha-Dihydrotestosterone is the… 
1998
1998
Pharmacokinetics and pharmacodynamics of FK143, a nonsteroidal inhibitor of steroid 5α‐reductase, in healthy volunteers
1997
1997
Inhibition of Rat Prostate Carcinogenesis by a 5α-Reductase Inhibitor, FK143
BACKGROUND Androgen levels in the prostate may influence carcinogenesis in this organ. Inhibitors of the enzyme 5alpha-reductase… 
1997
1997
Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143.
BACKGROUND Androgen levels in the prostate may influence carcinogenesis in this organ. Inhibitors of the enzyme 5alpha-reductase… 
1997
1997
Effects of a new non-steroidal 5 alpha-reductase inhibitor, FK143, on the prostate gland in beagle dogs.
FK143 (4-[3-[3-[bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-yl] - butyric acid) is a new non-steroidal inhibitor of… 
1996
1996
FK-143 : 5ALPHA -REDUCTASE INHIBITOR TREATMENT OF BPH
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)